Aktie | index | MK | Wochen | |||
---|---|---|---|---|---|---|
Alkermes Plc NEU | NASDAQ Composite | M | 7 | 6 | 1.94 | 1 |
Novo Nordisk ADR | NYSE Composite | L | 4 | 6 | 11.42 | 16 |
Bristol-Meyers Squibb | S&P 500 | L | 4 | 7 | 3.91 | 2 |
Iqvia | S&P 500 | L | 3 | 5 | 1.58 | 2 |
Vertex Pharmaceuticals | NASDAQ 100 | L | 3 | 6 | 12.81 | 3 |
Charles River Laboratories | S&P 500 | L | 3 | 7 | 3.31 | 2 |
Gilead Sciences NEU | NASDAQ 100 | L | 3 | 6 | 2.3 | 1 |
Eli Lilly | S&P 500 | L | 2 | 6 | 3.12 | 3 |
Amgen | Dow Jones | L | 2 | 6 | 2.19 | 17 |
ICON PLC | NASDAQ Composite | L | 2 | 5 | 6.75 | 21 |
Teva ADR | NASDAQ Composite | L | 2 | 6 | 0.31 | 2 |
AbbVie | S&P 500 | L | 2 | 6 | 2.04 | 21 |
Zoetis | S&P 500 | L | 2 | 6 | 6.81 | 2 |
Johnson & Johnson | Dow Jones | L | 1 | 6 | 4 | 8 |
Ironwood | NASDAQ Composite | S | 1 | 7 | -0.02 | 2 |
AstraZeneca ADR | NYSE Composite | L | 1 | 7 | 2.35 | 21 |
Abbott Laboratories | NASDAQ Composite | L | 1 | 8 | 3.69 | 21 |
Simply Good Foods | NASDAQ Composite | M | 1 | 4 | 2.27 | 21 |
Dr Reddys Labs | NYSE Composite | L | 1 | 6 | - | 21 |
Regeneron Pharmaceuticals | NASDAQ 100 | L | 0 | 4 | 9.51 | 4 |
Burcon Nutrascience Corp | NASDAQ Composite | S | -1 | 1 | 4.89 | 21 |
USANA Health Sciences | NASDAQ Composite | S | -1 | 5 | 13.74 | 21 |
Cardinal Health | S&P 500 | L | -2 | 5 | 4.15 | 21 |
Biogen | NASDAQ 100 | L | -2 | 6 | 5.39 | 9 |
Corcept | NASDAQ Composite | M | -2 | 7 | 31.24 | 20 |
Arrowhead Pharma | NASDAQ Composite | M | -3 | 1 | 63.78 | 21 |
Catalent Inc | S&P 500 | L | -3 | 7 | 3.08 | 21 |
Insmed | NASDAQ Composite | M | -3 | 5 | 1.64 | 21 |
MediciNova | NASDAQ Composite | S | -4 | 1 | 33.45 | 21 |
McKesson | S&P 500 | L | -4 | 5 | 4.42 | 21 |
Canopy Growth | TSX | L | -4 | 2 | 2.66 | 21 |
Ionis Pharma | NASDAQ Composite | M | -4 | 4 | 3.31 | 21 |
EXACT Sciences | NASDAQ Composite | L | -5 | 4 | 5.52 | 21 |
Arcus Biosciences | NYSE Composite | S | -7 | 3 | 14.91 | 21 |
Alnylam | NASDAQ Composite | L | -7 | 4 | 3.07 | 21 |
Female Health | NASDAQ Composite | S | -7 | 5 | 3.2 | 21 |